부산대학교 도서관

van Bergen, Thijs; Bosch, Dennis A.; Bellanné-Chantelot, Christine; Mulet-Lazaro, Roger; Bledsoe, Jacob R.; Chen, Lanpeng; de Looper, Hans W. J.; van Dijk, Claire; ter Borg, Mariette N. D.; Bindels, Eric M. J.; Hoogenboezem, Remco M.; Roovers, Onno; Olofsen, Patricia A.; Bartels, Marije; van Montfrans, Joris; Breed, Puck; Salzer, Elisabeth; Holierhoek, Marloes G.; Nelken, Brigitte; Beaupain, Blandine; Fleming, Mark D.; Shimamura, Akiko; Raaijmakers, Marc H. G. P.; Donadieu, Jean; Newburger, Peter E.; Touw, Ivo P.; Aalbers, Anna M.

Blood Advances. 10(3):627-641

Blood. 139:1772-1772

Mulet-Lazaro R; Department of Hematology Erasmus University Medical Center, Erasmus MC Cancer Institute Rotterdam The Netherlands.; Sijs-Szabó A; Department of Hematology Erasmus University Medical Center, Erasmus MC Cancer Institute Rotterdam The Netherlands.; Department of Hematology Leiden University Medical Center Leiden The Netherlands.; Hoogenboezem RM; Department of Hematology Erasmus University Medical Center, Erasmus MC Cancer Institute Rotterdam The Netherlands.; van Herk S; Department of Hematology Erasmus University Medical Center, Erasmus MC Cancer Institute Rotterdam The Netherlands.; Exalto C; Department of Hematology Erasmus University Medical Center, Erasmus MC Cancer Institute Rotterdam The Netherlands.; Koenders JE; Department of Hematology Erasmus University Medical Center, Erasmus MC Cancer Institute Rotterdam The Netherlands.; Hoogeveen PG; Department of Immunology Erasmus University Medical Center Rotterdam The Netherlands.; Kavelaars FG; Department of Hematology Erasmus University Medical Center, Erasmus MC Cancer Institute Rotterdam The Netherlands.; Schelen AM; Department of Hematology Erasmus University Medical Center, Erasmus MC Cancer Institute Rotterdam The Netherlands.; van den Ancker W; Department of Hematology, Amsterdam University Medical Center Free University Amsterdam The Netherlands.; van de Loosdrecht AA; Department of Hematology, Amsterdam University Medical Center Free University Amsterdam The Netherlands.; Mullighan CG; Department of Pathology St. Jude Children's Research Hospital Memphis Tennessee USA.; Beverloo HB; Department of Clinical Genetics Erasmus University Medical Center Rotterdam The Netherlands.; van der Velden V; Department of Immunology Erasmus University Medical Center Rotterdam The Netherlands.; Cornelissen JJ; Department of Hematology Erasmus University Medical Center, Erasmus MC Cancer Institute Rotterdam The Netherlands.; Valk PJM; Department of Hematology Erasmus University Medical Center, Erasmus MC Cancer Institute Rotterdam The Netherlands.; Rijneveld AW; Department of Hematology Erasmus University Medical Center, Erasmus MC Cancer Institute Rotterdam The Netherlands.; Sanders MA; Department of Hematology Erasmus University Medical Center, Erasmus MC Cancer Institute Rotterdam The Netherlands.

Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Leonie Smeenk; Sophie Ottema; Roger Mulet-Lazaro; Anja Ebert; Marije Havermans; Andrea Arricibita Varea; Michaela Fellner; Dorien Pastoors; Stanley van Herk; Claudia Erpelinck-Verschueren; Tim Grob; Remco M. Hoogenboezem; François G. Kavelaars; Daniel R. Matson; Emery H. Bresnick; Eric M. Bindels; Alex Kentsis; Johannes Zuber; Ruud Delwel

Cancer Discovery. 11:2868-2883

Pastoors D; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Havermans M; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Mulet-Lazaro R; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Smeenk L; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Ottema S; Department of Clinical Genetics, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Erpelinck-Verschueren C; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; van Herk S; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Anthonissen M; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Grob T; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Subramanian S; School of Clinical Medicine, University of New South Wales, Sydney, Australia.; Oregon Health & Science University, Portland, OR.; Thoms JAI; School of Biomedical Sciences, University of New South Wales, Sydney, Australia.; Pimanda JE; School of Biomedical Sciences, University of New South Wales, Sydney, Australia.; Department of Clinical Haematology, Prince of Wales Hospital, Sydney, Australia.; Wouters BJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Beverloo B; Department of Clinical Genetics, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Haferlach T; Munich Leukemia Laboratory, Munich, Germany.; Haferlach C; Munich Leukemia Laboratory, Munich, Germany.; Zuber J; Research Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria.; Medical University of Vienna, Vienna BioCenter, Vienna, Austria.; Bindels E; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Delwel R; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Mulet-Lazaro R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van Herk S; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Nuetzel M; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Sijs-Szabo A; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Díaz N; Max Planck Institute for Molecular Biomedicine, Muenster, Germany.; Renewable Marine Resources Department, Institute of Marine Sciences (ICM-CSIC), Barcelona, Spain.; Kelly K; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Erpelinck-Verschueren C; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Schwarzfischer-Pfeilschifter L; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Stanewsky H; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Ackermann U; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Glatz D; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Raithel J; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Fischer A; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Pohl S; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Department of Conservative Dentistry and Periodontology, University Hospital Regensburg, Regensburg, Germany.; Rijneveld A; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Vaquerizas JM; Max Planck Institute for Molecular Biomedicine, Muenster, Germany.; MRC London Institute of Medical Sciences, London, United Kingdom.; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital 8 Campus, London, United Kingdom.; Thiede C; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.; Plass C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Wouters BJ; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. b.wouters@erasmusmc.nl.; Oncode Institute, Utrecht, the Netherlands. b.wouters@erasmusmc.nl.; Delwel R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. h.delwel@erasmusmc.nl.; Oncode Institute, Utrecht, the Netherlands. h.delwel@erasmusmc.nl.; Rehli M; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany. michael.rehli@klinik.uni-regensburg.de.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany. michael.rehli@klinik.uni-regensburg.de.; Gebhard C; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany. claudia.gebhard@klinik.uni-regensburg.de.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany. claudia.gebhard@klinik.uni-regensburg.de.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Sollier E; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Riedel A; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Toprak UH; Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Wierzbinska JA; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Weichenhan D; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Schmid JP; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.; German Cancer Consortium (DKTK), Partner site Munich, A partnership between DKFZ and University Hospital LMU Munich, Munich, Germany.; Hakobyan M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, A partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Touzart A; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Université de Paris Cité, Institut Necker Enfants-Malades (INEM), Institut National de la Santé et de la Recherche Médicale (Inserm) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris, France.; Jahn E; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.; Vick B; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.; German Cancer Consortium (DKTK), Partner site Munich, A partnership between DKFZ and University Hospital LMU Munich, Munich, Germany.; Brown-Burke F; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Kelly K; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Kelekçi S; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Pejkovska A; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Goyal A; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Bähr M; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Breuer K; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Chen MM; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Llamazares-Prada M; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hartmann M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, A partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Schönung M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, A partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Correia N; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Trumpp A; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Abdullah Y; Division Systems Biology of Signal Transduction, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Klingmüller U; Division Systems Biology of Signal Transduction, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Mughal SS; Division Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Brors B; National Center for Tumor Diseases (NCT), NCT Heidelberg, A partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Medical Faculty and Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Westermann F; Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Ulrich E; German Cancer Consortium (DKTK), Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Autry RJ; German Cancer Consortium (DKTK), Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Schlesner M; Biomedical Informatics, Data Mining and Data Analytics, University of Augsburg, Augsburg, Germany.; Vosberg S; German Cancer Consortium (DKTK), Partner site Munich, A partnership between DKFZ and University Hospital LMU Munich, Munich, Germany.; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Herold T; German Cancer Consortium (DKTK), Partner site Munich, A partnership between DKFZ and University Hospital LMU Munich, Munich, Germany.; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Greif PA; German Cancer Consortium (DKTK), Partner site Munich, A partnership between DKFZ and University Hospital LMU Munich, Munich, Germany.; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Pfeifer D; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.; Lübbert M; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.; Fischer T; Department of Hematology and Oncology, Medical Center, Otto-von-Guericke University, Magdeburg, Germany.; Heidel FH; Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Germany.; Leibniz Institute on Aging, Fritz-Lipmann-Institute, Jena, Germany.; Gebhard C; Interventional Immunology, Leibniz Institute for Immunotherapy, Regensburg, Germany.; Walter W; MLL Munich Leukemia Laboratory, Munich, Germany.; Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany.; Eisfeld AK; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.; Mrózek K; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.; Nicolet D; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.; Bullinger L; Department of Hematology, Oncology, and Cancer Immunology, Charité, Universitätsmedizin Berlin, Berlin, Germany.; Smeenk L; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Erpelinck-Verschueren C; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Mulet-Lazaro R; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Delwel R; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Ernst A; German Cancer Consortium (DKTK), Heidelberg, Germany.; Group Genome Instability in Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Scherer M; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Lutsik P; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Oncology, KU Leuven, Leuven, Belgium.; Jeremias I; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.; German Cancer Consortium (DKTK), Partner site Munich, A partnership between DKFZ and University Hospital LMU Munich, Munich, Germany.; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany.; Döhner K; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.; Döhner H; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.; Lipka DB; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, A partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Faculty of Medicine, Otto-von-Guericke-University, Magdeburg, Germany.; Plass C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE

Fernandez-Orth J; Division of Pediatric Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany.; Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.; Koyunlar C; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Weiss JM; Division of Pediatric Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany.; Gioacchino E; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; de Looper H; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Andrieux G; Institute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Ter Borg M; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Zink J; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Gonzalez-Menendez I; Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard Karls University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' Eberhard Karls University of Tübingen, Tübingen, Germany.; Hoogenboezem R; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Yigit B; Division of Pediatric Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany.; Gussinklo KJ; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Mulet-Lazaro R; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Wantzen C; Division of Pediatric Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany.; Pfeiffer S; Division of Pediatric Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany.; Molnar C; Division of Pediatric Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany.; Bindels E; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Bohler S; Division of Pediatric Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany.; Sanders M; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Quintanilla-Martinez L; Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard Karls University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' Eberhard Karls University of Tübingen, Tübingen, Germany.; Wlodarski M; Division of Pediatric Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany.; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN.; Boerries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, A Partnership Between DKFZ and Medical Center - University of Freiburg, Freiburg, Germany.; Touw IP; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Niemeyer C; Division of Pediatric Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany.; Erlacher M; Division of Pediatric Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany.; Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.; de Pater E; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Mulet-Lazaro R; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Delwel R; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE

Hegde M; Department of Molecular, Cell and Cancer Biology; University of Massachusetts Chan Medical School, 364 Plantation Street, Worcester, MA, USA.; Ahmad MH; Department of Molecular, Cell and Cancer Biology; University of Massachusetts Chan Medical School, 364 Plantation Street, Worcester, MA, USA.; Mulet Lazaro R; Department of Hematology, Erasmus University Medical Center and Oncode Institute, Rotterdam, The Netherlands.; Sugita M; Department of Medicine, Weill Cornell Medical College, 1300 York Ave, New York, NY, USA.; Li R; Department of Molecular, Cell and Cancer Biology; University of Massachusetts Chan Medical School, 364 Plantation Street, Worcester, MA, USA.; Hu K; Department of Molecular, Cell and Cancer Biology; University of Massachusetts Chan Medical School, 364 Plantation Street, Worcester, MA, USA.; Gebhard C; Department of Internal Medicine III and Regensburg Centre for Interventional Immunology, University Hospital Regensburg, Regensburg, Germany.; Guzman ML; Department of Medicine, Weill Cornell Medical College, 1300 York Ave, New York, NY, USA.; Bushweller JH; Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, USA.; Zhu LJ; Department of Molecular, Cell and Cancer Biology; University of Massachusetts Chan Medical School, 364 Plantation Street, Worcester, MA, USA.; Brehm M; Program in Molecular Medicine, Diabetes Center of Excellence, University of Massachusetts Chan Medical School, 368 Plantation Street, Worcester, MA, USA.; Wolfe SA; Department of Molecular, Cell and Cancer Biology; University of Massachusetts Chan Medical School, 364 Plantation Street, Worcester, MA, USA.; Delwel R; Department of Hematology, Erasmus University Medical Center and Oncode Institute, Rotterdam, The Netherlands.; Castilla LH; Department of Molecular, Cell and Cancer Biology; University of Massachusetts Chan Medical School, 364 Plantation Street, Worcester, MA, USA. Lucio.Castilla@umassmed.edu.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Mulet-Lazaro R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Delwel R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE

Fischer A; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany; Leibniz Institute for Immunotherapy, Regensburg, Germany.; Hernández-Rodríguez B; Regulatory Genomics, Max Plank Institute for Molecular Medicine, Münster, Germany.; Mulet-Lazaro R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands.; Nuetzel M; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Hölzl F; Leibniz Institute for Immunotherapy, Regensburg, Germany.; van Herk S; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands.; Kavelaars FG; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Stanewsky H; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Ackermann U; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Niang AH; Regulatory Genomics, Max Plank Institute for Molecular Medicine, Münster, Germany.; Diaz N; Regulatory Genomics, Max Plank Institute for Molecular Medicine, Münster, Germany.; Reuschel E; Department of Obstetrics and Gynecology, Hospital St. Hedwig of the Order of St. John, Regensburg, Germany.; Strieder N; Leibniz Institute for Immunotherapy, Regensburg, Germany.; Hernández-López I; Leibniz Institute for Immunotherapy, Regensburg, Germany.; Valk PJM; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Vaquerizas JM; Regulatory Genomics, Max Plank Institute for Molecular Medicine, Münster, Germany; Department of Developmental Epigenomics, MRC London Institute of Medical Sciences, London, UK; Institute of Clinical Sciences, Imperial College London, London, UK.; Rehli M; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany; Leibniz Institute for Immunotherapy, Regensburg, Germany.; Delwel R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands.; Gebhard C; Leibniz Institute for Immunotherapy, Regensburg, Germany. Electronic address: claudia.gebhard@klinik.uni-regensburg.de.

Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Ashwin R. Iyer; Aishwarya Gurumurthy; Shih-Chun A. Chu; Rohan Kodgule; Athalee R. Aguilar; Travis Saari; Abdullah Ramzan; Jan Rosa; Juhi Gupta; Arvind Emmanuel; Cody N. Hall; John S. Runge; Anna B. Owczarczyk; Jang W. Cho; Matthew B. Weiss; Rockwell Anyoha; Kristin Sikkink; Savanna Gemus; Charles P. Fulco; Anamarija M. Perry; Anthony D. Schmitt; Jesse M. Engreitz; Noah A. Brown; Marcin P. Cieslik; Russell J.H. Ryan

Blood Cancer Discovery. 6:233-253

Pastoors D; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Oncode Institute, Utrecht, Netherlands.; Havermans M; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Oncode Institute, Utrecht, Netherlands.; Mulet-Lazaro R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Oncode Institute, Utrecht, Netherlands.; Brian D; Stem Cell Group, UCL Cancer Institute, University College London, London, UK.; Noort W; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer biology and immunology, Amsterdam, Netherlands.; Grasel J; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120 Heidelberg, Germany.; Division of Experimental Hematology, German Cancer Research Center, DKFZ69120 Heidelberg, Germany.; Hoogenboezem R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Smeenk L; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Oncode Institute, Utrecht, Netherlands.; Demmers JAA; Proteomics Center, Erasmus MC, Rotterdam, Netherlands.; Milsom MD; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120 Heidelberg, Germany.; Division of Experimental Hematology, German Cancer Research Center, DKFZ69120 Heidelberg, Germany.; Enver T; Stem Cell Group, UCL Cancer Institute, University College London, London, UK.; Groen RWJ; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer biology and immunology, Amsterdam, Netherlands.; Bindels E; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Delwel R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Oncode Institute, Utrecht, Netherlands.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE

Ottema S; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Mulet-Lazaro R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Erpelinck-Verschueren C; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; van Herk S; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Havermans M; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Arricibita Varea A; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Vermeulen M; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Beverloo HB; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.; Gröschel S; A380, German Cancer Research Center, Heidelberg, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Haferlach T; Munich Leukemia Laboratory, Munich, Germany.; Haferlach C; Munich Leukemia Laboratory, Munich, Germany.; J Wouters B; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Bindels E; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Smeenk L; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Delwel R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. h.delwel@erasmusmc.nl.; Oncode Institute, Utrecht, The Netherlands. h.delwel@erasmusmc.nl.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Gebhard C; Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Medical Center Regensburg, Regensburg, Germany.; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Mulet-Lazaro R; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Oncode Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Glatz D; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Schwarzfischer-Pfeilschifter L; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Schirmacher P; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Gaedcke J; Department of General and Visceral Surgery, University Medical Center, Göttingen, Germany.; Weichert W; Institute of Pathology, Technical University Munich (TUM), Munich, Germany.; Reuschel E; Department of Obstetrics and Gynecology, Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.; Dietmaier W; Institute of Pathology, University Hospital Regensburg, Regensburg, Germany.; Rehli M; Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Medical Center Regensburg, Regensburg, Germany.; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.

Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

Mulet-Lazaro R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Delwel R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.

Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Rein A; Department of Human Molecular Genetics and Biochemistry, Sackler Medical School, Aviv University, Aviv 69978, Israel; The Rina Zaizov Division of Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva; Israel; Functional Genomics and Childhood Leukaemia Research, Sheba Medical Centre, Tel-Hashomer.; Geron I; Department of Human Molecular Genetics and Biochemistry, Sackler Medical School, Aviv University, Aviv 69978, Israel; The Rina Zaizov Division of Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva; Israel; Functional Genomics and Childhood Leukaemia Research, Sheba Medical Centre, Tel-Hashomer, Israel; Felsenstein Medical Research Center, Sackler School of Medicine Tel-Aviv University, Petah Tikva.; Kugler E; Department of Human Molecular Genetics and Biochemistry, Sackler Medical School, Aviv University, Aviv 69978, Israel; The Rina Zaizov Division of Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva; Israel; Functional Genomics and Childhood Leukaemia Research, Sheba Medical Centre, Tel-Hashomer.; Fishman H; Department of Human Molecular Genetics and Biochemistry, Sackler Medical School, Aviv University, Aviv 69978, Israel; The Rina Zaizov Division of Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva; Israel; Functional Genomics and Childhood Leukaemia Research, Sheba Medical Centre, Tel-Hashomer.; Gottlieb E; Technion Integrated Cancer Center, Faculty of Medicine, Technion Israel Institute of Technology, Haifa.; Abramovich I; Technion Integrated Cancer Center, Faculty of Medicine, Technion Israel Institute of Technology, Haifa.; Giladi A; Department of Immunology, Weizmann Institute of Science, Rehovot.; Amit I; Department of Immunology, Weizmann Institute of Science, Rehovot.; Mulet-Lazaro R; Department of Hematology, Erasmus University Medical Center, Rotterdam, 3015 GE.; Delwel R; Department of Hematology, Erasmus University Medical Center, Rotterdam, 3015 GE, the Netherlands; Oncode Institute, Erasmus University Medical Center, Rotterdam.; Gröschel S; Department of Hematology, Erasmus University Medical Center, Rotterdam, 3015 GE, the Netherlands; Molecular Leukemogenesis, Deutsches Krebsforschungszentrum, 69120 Heidelberg, Germany; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg.; Levin-Zaidman S; Electron Microscopy Unit, Weizmann Institute of Science, Rehovot.; Dezorella N; Electron Microscopy Unit, Weizmann Institute of Science, Rehovot.; Holdengreber V; Electron Microscopy Unit, IDRFU, Faculty of Life Sciences, Aviv University.; Rao TN; Stem Cells and Leukemia Laboratory, University Clinic of Hematology and Central Hematology, Department of Biomedical Research (DBMR), Inselspital Bern, University of Bern.; Yacobovich J; The Rina Zaizov Division of Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva.; Steinberg-Shemer O; The Rina Zaizov Division of Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva; Israel; Felsenstein Medical Research Center, Sackler School of Medicine Tel-Aviv University, Petah Tikva.; Huang QH; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital, Jiao Tong University School of Medicine, Shanghai 200025.; Tan Y; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital, Jiao Tong University School of Medicine, Shanghai 200025.; Chen SJ; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital, Jiao Tong University School of Medicine, Shanghai 200025.; Izraeli S; Department of Human Molecular Genetics and Biochemistry, Sackler Medical School, Aviv University, Aviv 69978, Israel; The Rina Zaizov Division of Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva; Israel; Functional Genomics and Childhood Leukaemia Research, Sheba Medical Centre, Tel-Hashomer, Israel; Felsenstein Medical Research Center, Sackler School of Medicine Tel-Aviv University, Petah Tikva. sizraeli@gmail.com.; Birger Y; Department of Human Molecular Genetics and Biochemistry, Sackler Medical School, Aviv University, Aviv 69978, Israel; The Rina Zaizov Division of Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva; Israel; Functional Genomics and Childhood Leukaemia Research, Sheba Medical Centre, Tel-Hashomer, Israel; Felsenstein Medical Research Center, Sackler School of Medicine Tel-Aviv University, Petah Tikva. yehudit.birger@gmail.com.

Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

Russell J.H. Ryan; Marcin P. Cieslik; Noah A. Brown; Jesse M. Engreitz; Anthony D. Schmitt; Anamarija M. Perry; Charles P. Fulco; Savanna Gemus; Kristin Sikkink; Rockwell Anyoha; Matthew B. Weiss; Jang W. Cho; Anna B. Owczarczyk; John S. Runge; Cody N. Hall; Arvind Emmanuel; Juhi Gupta; Jan Rosa; Abdullah Ramzan; Travis Saari; Athalee R. Aguilar; Rohan Kodgule; Shih-Chun A. Chu; Aishwarya Gurumurthy; Ashwin R. Iyer

Tanaka A; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.; Laboratory of Immunology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.; Nakano TA; Department of Pediatrics, Section of Hematology, Oncology and Bone Marrow Transplantation, University of Colorado, Aurora, CO.; Nomura M; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.; Facility for iPS Cell Therapy, CiRA Foundation, Kyoto, Japan.; Yamazaki H; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.; Bewersdorf JP; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Mulet-Lazaro R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Hogg S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Liu B; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Penson A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Yokoyama A; Tsuruoka Metabolomics Laboratory, National Cancer Center, Yamagata, Japan.; Zang W; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Havermans M; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Koizumi M; Field of Human Disease Models, Major in Advanced Life Sciences and Medicine, Tokyo Women's Medical University, Tokyo, Japan.; Hayashi Y; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.; Cho H; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Kanai A; Department of Molecular Oncology and Leukemia Program Project, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.; Lee SC; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.; Xiao M; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Koike Y; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.; Zhang Y; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Fukumoto M; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.; Aoyama Y; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Konuma T; Structural Epigenetics Laboratory, and.; Kunimoto H; Department of Stem Cell and Immune Regulation, Graduate School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan.; Inaba T; Department of Molecular Oncology and Leukemia Program Project, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.; Nakajima H; Department of Stem Cell and Immune Regulation, Graduate School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan.; Honda H; Field of Human Disease Models, Major in Advanced Life Sciences and Medicine, Tokyo Women's Medical University, Tokyo, Japan.; Kawamoto H; Laboratory of Immunology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.; Delwel R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Abdel-Wahab O; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Inoue D; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE